Asthma Trial, Recruiting (NCT06609941)

Asthma Trial, Recruiting NCT06609941 Sponsor: Foundation University Islamabad Condition: Asthma

Printed from Voxsanity (voxsanity.com.au) — NCT06609941 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Asthma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults between 18 and 45 years old
Both men and women are welcome to apply
People who experience breathlessness ranging from mild to severe, as measured by a standard breathing difficulty scale called the Modified MRC Dyspnea Scale (Grades 1 to 4)
People diagnosed with mild persistent or moderate persistent asthma, based on national asthma guidelines (confirm with trial site)

Who may not be able to join:

People currently experiencing a sudden, severe worsening of COPD or a severe, life-threatening asthma attack
People who currently have an acute (sudden or active) infection
People who are unable to understand or follow instructions
Asthma patients whose "control pause" breathing measurement is longer than 40 seconds (confirm with trial site)
Asthma patients whose peak breathing flow (a measure of how well air moves out of the lungs) is less than 50% of their normal level, which places them in the "red zone" of their asthma action plan, indicating poor asthma control

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0333-1281293

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06609941

Sponsor: Foundation University Islamabad

Phase: Not Applicable

Status: Recruiting

Condition: Asthma

Trial contact: 0333-1281293

More information: https://clinicaltrials.gov/study/NCT06609941

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults between 18 and 45 years old
Both men and women are welcome to apply
People who experience breathlessness ranging from mild to severe, as measured by a standard breathing difficulty scale called the Modified MRC Dyspnea Scale (Grades 1 to 4)
People diagnosed with mild persistent or moderate persistent asthma, based on national asthma guidelines (confirm with trial site)

Who may not be able to join:

People currently experiencing a sudden, severe worsening of COPD or a severe, life-threatening asthma attack
People who currently have an acute (sudden or active) infection
People who are unable to understand or follow instructions
Asthma patients whose "control pause" breathing measurement is longer than 40 seconds (confirm with trial site)
Asthma patients whose peak breathing flow (a measure of how well air moves out of the lungs) is less than 50% of their normal level, which places them in the "red zone" of their asthma action plan, indicating poor asthma control

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Foundation University Islamabad

Registry

ClinicalTrials.gov

Start date

18 June 2024

Est. completion

1 January 2025

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Dyspnea; Control pause; Asthma control; Peak expiratory flow rate.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov